U.S. Markets closed

ZoomMed: ZRx Prescriber Soon Available for Download on the "App Store"

MONTREAL, QUEBEC--(Marketwire - Feb 7, 2013) - ZoomMed inc. (TSX VENTURE:ZMD), is proud to announce the ZRx Prescriber will soon be available for download on the "App Store" by all potential users throughout North America.

"Having the ZRx Prescriber on the "App Store" will constitute an additional and privileged channel for the promotion and deployment of our electronic prescriber". I am confident that this new technology showcase for ZRx, will contribute significantly to the success of ZoomMed." said Mr. Yves Marmet, President and Chief Executive Officer.

"I am also very pleased to remind our shareholders and investors that, on January 28, 2013, ZoomMed published its financial results for the periods ended November 30, 2012 and 2011, and that as a result of business development and marketing efforts, the company posted an increase in revenue and a net profit for the quarter ended November 30, 2012. " added Mr. Marmet.

  • For the quarter ended November 30, 2012, operating revenue amounted to $1,301,470 compared to $701,231 for the corresponding 2011 quarter, an increase of 86%. For the six-month period ended November 30, 2012, operating revenues amounted to $2,323,400 compared to $1,266,870 for the corresponding 2011 quarter, an increase of 83%.
  • The Company recorded a net operating benefit of $75,241 for the three-month period ended November 30, 2012, compared to a net loss of $854,884 for the three-month period ended November 30, 2011. The Company recorded a net operating loss of $26,250 for the six-month period ended November 30, 2012 compared to $1,610,715 loss for the six-month period ended November 30, 2011.

Since the beginning of fiscal year 2013, ZoomMed has signed several new agreements with ClearMedica, ANDX Logic and OscarService Inc. for the integration and marketing of the ZRx Prescriber. These agreements allow ZoomMed to offer its services to more than 900 new physicians throughout Canada.

"The ZRx Prescriber reached new frontiers"